Eli Lilly & Co. (LLY) call put ratio 2.1 calls to 1 put
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
BofA Securities Reiterates Buy Rating on Eli Lilly (LLY)
January 24, 2025 12:14 PM ESTBofA Securities analyst Tim Anderson reiterated a Buy rating and $997.00 price target on Eli Lilly (NYSE: LLY).
The analyst comments "This morning, Novo Nordisk (NOVO) shared topline data from its ph1/2a study with subQ amycretin in 125 patients with overweight or obesity a... More
